Colonoscopy Using Motorized Spiral Enteroscope

June 17, 2022 updated by: Abdulbaqi Al-Toma, St. Antonius Hospital

Colonoscopy Using Motorized Spiral Enteroscope: Prospective Bi-center Study

The new technology of the motorized Spiral enteroscope, originally developed for deep small bowel enteroscopy, might potentially overcome some limitations of standard colonoscopy.

Study Overview

Detailed Description

Cecal intubation rate represents a key procedural quality parameter in diagnostic colonoscopy. However, even in experienced hands, a significant percentage of colonoscopies (1.6-16.7%) remain incomplete because of a failure to intubate the cecum. The new technology of the motorized Spiral enteroscope, originally developed for deep small bowel enteroscopy, might potentially overcome some limitations of standard colonoscopy. The study aim was to evaluate the feasibility and safety of motorized Spiral enteroscopy for difficult colonoscopies.

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Groningen, Netherlands, 9700 RB
        • University Medical Centre Groningen
      • Nieuwegein, Netherlands, 3430 EM
        • St Antonius Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients with failed colonoscopies using the conventional standrad colonoscopy devices.

Description

Inclusion Criteria:

- Indications for Spiral colonoscopy as a rescue procedure because of incomplete antecedent colonoscopy

Exclusion Criteria:

  • Age under 18 years
  • Known pregnancy
  • Poor health status (ASA classification ≥ 4)
  • Contraindication for sedation or standard colonoscopy
  • Known coagulopathy (INR ≥ 2.0, platelets < 70 /nl) or anticoagulants other than aspirin
  • Medical history of chronic inflammatory bowel disease or suspected bowel obstruction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental: Motorized spiral Enteroscopy
Consecutive patients with difficult colonoscopies to be enrolled to achieve total colonoscopy using the motorized spiral enteroscope.
The feasibility of the motorized spiral enteroscope to achieve cecum intubation in difficult colons.
The feasibility of the motorized spiral enteroscope for performing interventions such as polypectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluate the feasibility of motorized PowerSpiral enteroscopy for difficult colonoscopies
Time Frame: during procedure
achieving cecum intubation in difficult colons
during procedure
evaluate the safety of motorized PowerSpiral enteroscopy for difficult colonoscopies
Time Frame: 7 days
Registering adverse events
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endoscopic mucosal resection
Time Frame: during procedure
Performing endoscopic mucosal resection on polyps
during procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abdulbaqi Al-Toma, Ph.D., St. Antonius Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 25, 2021

Primary Completion (ACTUAL)

May 31, 2022

Study Completion (ACTUAL)

May 31, 2022

Study Registration Dates

First Submitted

May 17, 2021

First Submitted That Met QC Criteria

May 17, 2021

First Posted (ACTUAL)

May 20, 2021

Study Record Updates

Last Update Posted (ACTUAL)

June 21, 2022

Last Update Submitted That Met QC Criteria

June 17, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Disease

Clinical Trials on Diagnostic colonoscopy

Subscribe